Effect Of Jalaukavacharan In Reducing Duration Of Inflammation In Vranashopha (Cellulitis) Compare With Glycerine Magnesium Sulphate Dressing: A Randomized Controlled Trial
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 56
- 试验地点
- 1
- 主要终点
- This study may provide use of jalaukavacharan in reducing duration of inflammation in Vranashopha
研究概览
简要总结
This study will be carried out at opd of shalyatantra of Pakwasa Samnvay Rugnalaya Nagpur .This is an open label randomized controlled trial aims at studying the effect of jalaukavacharan in reducing duration of inflammation in vranashopha (cellulitis) comparing with glycerine magnesium sulphate dressing . Total 56 patients will be included and will be randomly divided into two groups i.e. Group A and Group B each containing 28 patients.Group A will be trial group where patients will receive Jalaukavacharan and Group B will be control group will receive application of glycerine magnesium sulphate dressing . Then patients will be observed on 1st, 3rd,5th,7th and 9st day. All the findings will be recorded in case record form, At the end of trial,collected data will be analyzed and result will be drawn accordingly.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- All
入选标准
- •1.Diagnosed case of amavastha and pachyamana avastha of Vranashopha.
- •2.Patient of age group between 18-60 years.
- •3.Patient fit for Raktamokshana.
- •4.Cellulitis due to varicosity.
排除标准
- •1.Pakwavastha of Vranashopha.
- •2.Uncontrolled systemic diseasis such as HTN,DM etc 3.Immuno-compromised patients 4.Severe anemia.
- •5.Septicemia.
- •6.Morbid obesity.
结局指标
主要结局
This study may provide use of jalaukavacharan in reducing duration of inflammation in Vranashopha
时间窗: At the end of 9 days
次要结局
- comparative effect of reducing duration of inflammation in vranashopha between jalaukavacharan and glycerin magnesium sulphate dressing will be assessed.(At the end of 9 days)
研究者
Dr Prakash Vishwambhar Failwad
Shri Ayurved Mahavidyalaya,Nagpur
